These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 31307991

  • 1. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.
    G C B, Sahukhal GS, Elasri MO.
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of the msaABCR operon in implant-associated chronic osteomyelitis in Staphylococcus aureus USA300 LAC.
    Sahukhal GS, Tucci M, Benghuzzi H, Wilson G, Elasri MO.
    BMC Microbiol; 2020 Oct 27; 20(1):324. PubMed ID: 33109085
    [Abstract] [Full Text] [Related]

  • 5. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
    Hort M, Bertsche U, Nozinovic S, Dietrich A, Schrötter AS, Mildenberger L, Axtmann K, Berscheid A, Bierbaum G.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0052821. PubMed ID: 34668723
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
    Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K.
    J Antimicrob Chemother; 1998 Aug 31; 42(2):199-209. PubMed ID: 9738837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. msaABCR operon is involved in persister cell formation in Staphylococcus aureus.
    Sahukhal GS, Pandey S, Elasri MO.
    BMC Microbiol; 2017 Nov 22; 17(1):218. PubMed ID: 29166860
    [Abstract] [Full Text] [Related]

  • 11. Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.
    Périchon B, Courvalin P.
    Antimicrob Agents Chemother; 2006 Nov 22; 50(11):3622-30. PubMed ID: 16954318
    [Abstract] [Full Text] [Related]

  • 12. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.
    Qureshi NK, Yin S, Boyle-Vavra S.
    PLoS One; 2014 Nov 22; 9(1):e85873. PubMed ID: 24454941
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The msaABCR Operon Regulates the Response to Oxidative Stress in Staphylococcus aureus.
    Pandey S, Sahukhal GS, Elasri MO.
    J Bacteriol; 2019 Nov 01; 201(21):. PubMed ID: 31427392
    [Abstract] [Full Text] [Related]

  • 16. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
    Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A.
    PLoS Pathog; 2012 Feb 01; 8(2):e1002505. PubMed ID: 22319446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional profiling of CHAP domain-containing peptidoglycan hydrolases of Staphylococcus aureus USA300 uncovers potential targets for anti-staphylococcal therapies.
    Wang M, Li X, Cavallo FM, Yedavally H, Piersma S, Raineri EJM, Vera Murguia E, Kuipers J, Zhang Z, van Dijl JM, Buist G.
    Int J Med Microbiol; 2024 Sep 01; 316():151632. PubMed ID: 39142057
    [Abstract] [Full Text] [Related]

  • 20. Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?
    Ortwine JK, Werth BJ, Sakoulas G, Rybak MJ.
    Drug Resist Updat; 2013 Sep 01; 16(3-5):73-9. PubMed ID: 24268586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.